IL1B and neurodegenerative disease: The robust NLRP3 inflammasome response, upregulation of NLRP3 and IL-1β following LPS + ATP/NG stimulation, highlights their relevance for studies of inflammasome-targeting drugs in neurodegenerative diseases.